Log In
BCIQ
Print this Print this
 

RG7458

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionAnti-MUC16,DMUC5754A antibody-drug conjugate (ADC)
Molecular Target Mucin 16 (MUC16) (CA125)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation
PartnerSeattle Genetics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today